⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RMD News
ResMed Inc.
XOVR Exceeds $200 Million in Private-Equity Exposure; Completes Transparency Reset
prnewswire.com
NVDA
META
ARCC
IBKR
PLTR
RMD
GOOGL
TSLA
ラピッド・メディカル、DISTALS試験の極めてポジティブな結果で中型血管性脳卒中におけるTIGERTRIEVER™ 13の優れた再灌流効果を実証
businesswire.com
RMD
L’essai DISTALS de Rapid Medical™ est extrêmement positif, montrant une reperfusion supérieure avec TIGERTRIEVER™ 13 après un AVC des vaisseaux de moyen calibre
businesswire.com
RMD
Rapid Medical™的DISTALS试验结果极为积极，证实TIGERTRIEVER™ 13对治疗中血管卒中具有卓越的再灌注效果
businesswire.com
RMD
Die DISTALS-Studie von Rapid Medical™ ist äußerst positiv und belegt eine überlegene Reperfusion mit TIGERTRIEVER™ 13 bei Schlaganfällen in mittleren Gefäßen
businesswire.com
RMD
TIGERTRIEVER™ 13 logra una reperfusión superior en ictus de vasos medianos, según ensayos DISTALS de Rapid Medical™
businesswire.com
RMD
Rapid Medical™’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke
businesswire.com
RMD
Sleep Testing Services Research Report 2026 - Global Market Trends, Competitive Analysis, Opportunities, and Forecasts, 2021-2025 & 2026-2031
globenewswire.com
RMD
AAPL
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
globenewswire.com
RMD
Breakthru Medicine emerges from stealth with $60M Series A for cancer drug development
globenewswire.com
RMD
GILD